MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 17.180
- -0.220-1.26%
Close Dec 20 16:00 ET
- 17.840
- +0.660+3.84%
Post 20:01 ET
1.50BMarket Cap-3.75P/E (TTM)
17.880High17.130Low3.70MVolume17.130Open17.400Pre Close63.91MTurnover5.01%Turnover RatioLossP/E (Static)87.03MShares20.33052wk High-49.09P/B1.27BFloat Cap5.12052wk Low--Dividend TTM73.88MShs Float37.040Historical High--Div YieldTTM4.31%Amplitude0.000Historical Low17.275Avg Price1Lot Size
Travere Therapeutic Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 42.82%-42.56M | 59.41%-39.83M | -34.60%-119.01M | -24.73%-325.36M | 16.08%-64.37M | 19.11%-74.43M | -166.64%-98.14M | -59.83%-88.42M | -242.15%-260.85M | 13.16%-76.7M |
| Net income from continuing operations | 38.65%-54.75M | 37.99%-69.55M | -57.60%-136.06M | -13.54%-376.33M | -3.46%-88.6M | 13.21%-89.24M | -67.33%-112.17M | -13.64%-86.33M | -52.54%-331.47M | 3.53%-85.64M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.58M | --0 |
| Depreciation and amortization | -2.06%11.24M | -5.50%10.35M | 49.24%9.88M | 85.96%38.53M | 50.32%9.49M | 1,547.04%11.48M | 35.01%10.95M | -6.66%6.62M | 62.55%20.72M | 180.71%6.31M |
| Other non cash items | 2,200.94%64.88M | 155.84%4.99M | -94.13%364K | -164.29%-1.91M | 262.18%3.91M | 62.99%-3.09M | -293.98%-8.93M | -31.97%6.2M | -80.80%2.97M | 85.14%-2.41M |
| Change In working capital | -37.65%-6.74M | -819.98%-60.74M | 86.02%-2.95M | -3,011.43%-25.48M | 265.76%7.1M | -139.17%-4.9M | -265.75%-6.6M | -86.18%-21.08M | -98.92%875K | -126.83%-4.28M |
| -Change in receivables | -193.12%-731K | -400.87%-1.74M | 66.79%-1.55M | -687.94%-11.3M | -25.49%-8M | -86.28%785K | 128.64%578K | -475.34%-4.66M | -107.99%-1.43M | -291.05%-6.38M |
| -Change in inventory | 94.84%-246K | 87.95%-1.42M | -257.65%-1.82M | -3,160.55%-39.42M | -59,028.95%-22.39M | -686.22%-4.77M | -517.50%-11.75M | -224.84%-510K | -1,133.33%-1.21M | -92.35%38K |
| -Change in prepaid assets | 37.27%-3.05M | -71.62%866K | -4.81%-2.72M | 10.37%-4.66M | 90.20%-255K | -1,788.72%-4.85M | 202.25%3.05M | -501.08%-2.6M | -261.08%-5.2M | -529.54%-2.6M |
| -Change in payables and accrued expense | -107.33%-554K | -1,120.74%-53.45M | 63.52%-3.37M | 94.27%47.08M | 416.48%43.52M | -21.73%7.56M | -65.49%5.24M | -2.34%-9.23M | 26.59%24.24M | -51.12%8.43M |
| -Change in other current liabilities | -2.48%-248K | -290.91%-2.88M | 3,477.31%8.04M | 74.02%-418K | 56.67%799K | -3,125.00%-242K | -209.66%-737K | 87.40%-238K | -243.28%-1.61M | -62.50%510K |
| -Change in other working capital | 43.32%-1.91M | 28.80%-2.12M | 60.41%-1.52M | -20.50%-16.77M | -53.50%-6.57M | 1.95%-3.38M | 26.37%-2.98M | -79.12%-3.84M | -131.71%-13.91M | -103.76%-4.28M |
| Cash from discontinued investing activities | -99.67%50K | -39.19%45.34M | -127.65%-6.1M | 15.29M | 21.33%74.56M | 22.06M | ||||
| Operating cash flow | 28.12%-42.51M | 41.93%-40.24M | -46.71%-119.01M | -50.31%-280.02M | -28.98%-70.47M | -49.61%-59.13M | -88.28%-69.3M | -46.63%-81.12M | -1,159.40%-186.29M | -103.30%-54.64M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 163.31%46.13M | 221.47%28.61M | 383.21%104.9M | -365.78%-151.63M | 50.47%-18.18M | -822.85%-72.86M | 39.76%-23.55M | -211.68%-37.04M | 76.35%-32.55M | -597.98%-36.7M |
| Net PPE purchase and sale | --0 | -2,633.33%-82K | --0 | -249.74%-668K | 16.67%-25K | ---10K | ---3K | -380.92%-630K | 96.26%-191K | 80.52%-30K |
| Net intangibles purchase and sale | -66.64%-8.19M | -1,906.55%-76.91M | 76.35%-6.47M | -46.62%-41.59M | -32.11%-5.51M | 35.49%-4.92M | 66.50%-3.83M | -432.26%-27.34M | -48.90%-28.37M | 17.42%-4.17M |
| Net investment purchase and sale | 179.96%54.32M | 635.59%105.6M | 1,327.56%111.36M | -3,120.47%-109.37M | 60.36%-12.65M | -483.53%-67.93M | 28.65%-19.72M | -123.61%-9.07M | 97.01%-3.4M | -353.81%-31.9M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---600K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -65.40%46.13M | 221.47%28.61M | 383.21%104.9M | 271.34%55.78M | 53.82%-16.95M | 1,222.73%133.32M | 39.76%-23.55M | -211.68%-37.04M | 76.35%-32.55M | -597.98%-36.7M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 112.30%46K | -69.03%782K | -100.24%-525K | 83.37%220.13M | -66.84%383K | -109.01%-374K | 203.85%2.53M | 91.02%217.6M | -49.51%120.05M | -97.06%1.16M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --104.93M | --0 |
| Net common stock issuance | --0 | --0 | --0 | 878.25%191.2M | --0 | --0 | ---1K | 878.25%191.2M | -91.31%19.55M | --0 |
| Proceeds from stock option exercised by employees | 278.15%571K | -57.16%1.31M | --0 | 310.37%31.04M | -45.95%908K | -95.57%151K | 29.61%3.05M | 21,970.49%26.93M | -49.42%7.56M | -76.00%1.68M |
| Net other financing activities | 0.00%-525K | 0.00%-525K | 0.00%-525K | 82.47%-2.1M | 0.00%-525K | -170.38%-525K | 65.53%-525K | 95.08%-525K | -470.57%-11.98M | -134.09%-525K |
| Cash from discontinued financing activities | 0 | 0 | 0 | 44.25%-1.38M | 57.12%-259K | -260K | -259K | -604K | 59.39%-2.48M | -604K |
| Financing cash flow | 107.26%46K | -65.49%782K | -100.24%-525K | 86.06%218.75M | -77.50%124K | -127.83%-634K | 172.68%2.27M | 90.49%217M | -49.25%117.57M | -98.34%551K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.44%32.29M | -73.20%43.25M | -5.69%58.18M | -62.78%61.69M | -4.69%144.24M | -60.57%70.87M | -37.10%161.38M | -62.78%61.69M | 95.53%165.75M | 0.67%151.34M |
| Current changes in cash | -95.02%3.67M | 88.02%-10.85M | -114.80%-14.63M | 94.58%-5.49M | 3.85%-87.3M | 370.72%73.55M | -20.66%-90.58M | 7.72%98.84M | -227.76%-101.27M | -762.41%-90.79M |
| Effect of exchange rate changes | 351.67%453K | -232.93%-109K | -134.55%-293K | 170.90%1.98M | 7.89%1.23M | 85.65%-180K | 104.71%82K | 190.31%848K | -263.11%-2.79M | -33.66%1.14M |
| End cash Position | -74.76%36.41M | -54.44%32.29M | -73.20%43.25M | -5.69%58.18M | -5.69%58.18M | -4.69%144.24M | -60.57%70.87M | -37.10%161.38M | -62.78%61.69M | -62.78%61.69M |
| Free cash flow | 20.86%-50.7M | -60.31%-117.24M | -15.02%-125.47M | -50.00%-322.28M | -29.18%-76M | -35.42%-64.06M | -51.99%-73.13M | -80.05%-109.08M | -451.70%-214.85M | -83.42%-58.84M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.